Company news
Cerus Corporation (NASDAQ:CERS) news
Every Cerus Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Cerus Corporation Announces Second Quarter 2026 Financial Results
July 30, 2026
Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
July 16, 2026
Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress
June 17, 2026
Cerus Corporation Closes New Debt Facility of Up to $110 Million
June 8, 2026
Bradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann Lucena
May 27, 2026
Cerus Corporation Announces First Quarter 2026 Financial Results
April 30, 2026
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
April 27, 2026
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
April 16, 2026
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer
March 16, 2026
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results
March 2, 2026
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
February 20, 2026
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026
February 17, 2026
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treate...
January 22, 2026
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
January 11, 2026
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
December 10, 2025
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
November 6, 2025
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
October 21, 2025
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
October 16, 2025
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
August 25, 2025
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025
August 21, 2025
Cerus Corporation Announces Second Quarter 2025 Financial Results
August 5, 2025
Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025
July 22, 2025
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
July 21, 2025
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
July 2, 2025
Cerus Corporation Celebrates World Blood Donor Day 2025
June 13, 2025
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
June 3, 2025
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congr...
May 29, 2025
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device
May 28, 2025
Cerus Corporation Announces First Quarter 2025 Financial Results
May 1, 2025
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
April 17, 2025
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
March 5, 2025
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results
February 20, 2025
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference
February 19, 2025
Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025
February 7, 2025
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
January 13, 2025
Cerus Corporation to Participate in Upcoming Investor Conferences
November 13, 2024
Cerus Corporation Announces Third Quarter 2024 Financial Results
October 30, 2024
Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
October 18, 2024
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
October 18, 2024
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
October 16, 2024
Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
August 1, 2024
Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024
July 18, 2024
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
July 2, 2024
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
June 21, 2024
Cerus Corporation Celebrates World Blood Donor Day 2024
June 14, 2024
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
May 22, 2024
Cerus Corporation Announces First Quarter 2024 Financial Results
May 2, 2024
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
April 18, 2024
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
March 26, 2024
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in ...
March 19, 2024